These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9878871)

  • 1. Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia.
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Brain Res; 1999 Jan; 816(2):471-9. PubMed ID: 9878871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective properties of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia.
    Schmid-Elsaesser R; Zausinger S; Hungerhaber E; Baethmann A; Reulen HJ
    Acta Neurochir Suppl; 1997; 70():176-8. PubMed ID: 9416314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Plesnila N; Baethmann A; Reulen HJ
    Stroke; 1997 Oct; 28(10):2018-24. PubMed ID: 9341713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN).
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Exp Brain Res; 2000 Jan; 130(1):60-6. PubMed ID: 10638441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with dextromethorphan or tirilazad--but not a combination of both--improves outcome after transient focal cerebral ischemia in rats.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
    Exp Brain Res; 1998 Sep; 122(1):121-7. PubMed ID: 9772119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination drug therapy and mild hypothermia after transient focal cerebral ischemia in rats.
    Zausinger S; Schöller K; Plesnila N; Schmid-Elsaesser R
    Stroke; 2003 Sep; 34(9):2246-51. PubMed ID: 12893947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats.
    Soehle M; Heimann A; Kempski O
    Stroke; 1998 Jun; 29(6):1240-6; discussion 1246-7. PubMed ID: 9626300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia.
    Schmid-Elsaesser R; Zausinger S; Hungerhuber E; Baethmann A; Reulen HJ
    Neurosurgery; 1999 Jan; 44(1):163-71; discussion 171-2. PubMed ID: 9894977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination drug therapy and mild hypothermia: a promising treatment strategy for reversible, focal cerebral ischemia.
    Schmid-Elsaesser R; Hungerhuber E; Zausinger S; Baethmann A; Reulen HJ
    Stroke; 1999 Sep; 30(9):1891-9. PubMed ID: 10471442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons.
    Andrus PK; Fleck TJ; Oostveen JA; Hall ED
    J Neurosci Res; 1997 Mar; 47(6):650-4. PubMed ID: 9089214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen.
    Zausinger S; Westermaier T; Plesnila N; Steiger HJ; Schmid-Elsaesser R
    Stroke; 2003 Jun; 34(6):1526-32. PubMed ID: 12730554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective efficacy of intra-arterial and intravenous magnesium sulfate in a rat model of transient focal cerebral ischemia.
    Westermaier T; Hungerhuber E; Zausinger S; Baethmann A; Schmid-Elsaesser R
    Acta Neurochir (Wien); 2003 May; 145(5):393-9; discussion 399. PubMed ID: 12820046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the pyrrolopyrimidine lipid peroxidation inhibitor U-101033E on neuronal and astrocytic metabolism and infarct volume in rats with transient middle cerebral artery occlusion.
    Håberg A; Qu H; Hjelstuen MH; Sonnewald U
    Neurochem Int; 2007 Jun; 50(7-8):932-40. PubMed ID: 17241701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models.
    Hall ED; Andrus PK; Smith SL; Fleck TJ; Scherch HM; Lutzke BS; Sawada GA; Althaus JS; Vonvoigtlander PF; Padbury GE; Larson PG; Palmer JR; Bundy GL
    J Pharmacol Exp Ther; 1997 May; 281(2):895-904. PubMed ID: 9152399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats.
    Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R
    Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection in ischemic stroke--combination drug therapy and mild hypothermia in a rat model of permanent focal cerebral ischemia.
    Schöller K; Zausinger S; Baethmann A; Schmid-Elsaesser R
    Brain Res; 2004 Oct; 1023(2):272-8. PubMed ID: 15374753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of a postischemic treatment with a bradykinin B2 receptor antagonist in a rat model of temporary focal cerebral ischemia.
    Lumenta DB; Plesnila N; Kläsner B; Baethmann A; Pruneau D; Schmid-Elsaesser R; Zausinger S
    Brain Res; 2006 Jan; 1069(1):227-34. PubMed ID: 16378603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic time window for the 21-aminosteroid, U-74389G, in global cerebral ischemia.
    Lee SH; Kondoh T; Camarata PJ; Heros RC
    Neurosurgery; 1996 Mar; 38(3):517-21; discussion 522. PubMed ID: 8837804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The neuroprotective effect of the glutamate antagonist acamprosate following experimental cerebral ischemia. A study with the lipid peroxidase inhibitor u-101033e].
    Engelhard K; Werner C; Lu H; Möllenberg O; Zieglgänsberger W; Kochs E
    Anaesthesist; 2000 Sep; 49(9):816-21. PubMed ID: 11076270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.